Fluid therapy in critical illness: A special focus on indication, the use of hydroxyethyl starch and its different raw materials

Current Opinion in Anaesthesiology

Volumn 26, Issue 3, 2013, Pages 253-260

  Ertmer, Christian ^a   Kampmeier, Tim ^a   Van Aken, Hugo ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Acute kidney injury; Fluid therapy; Hydroxyethyl starch; Transfusion

Indexed keywords

HETASTARCH; COLLOID; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ADVERSE OUTCOME; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CRYSTALLOID; FLUID THERAPY; HEMODILUTION; HUMAN; INFLAMMATION; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT INDICATION; CHEMISTRY; COLLOID; INTENSIVE CARE; META ANALYSIS (TOPIC); PROCEDURES; RESUSCITATION; SEPSIS; THERAPEUTIC USE;

COLLOIDS; CRITICAL CARE; CRITICAL ILLNESS; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; META-ANALYSIS AS TOPIC; PLASMA SUBSTITUTES; RESUSCITATION; SEPSIS;

EID: 84877765281     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Lewins R. Injection of saline solutions in extraordinary quantities into the veins in cases of malignant cholera. Lancet 1832; 18:243-244
2. Latta T. Malignant cholera: Documents communicated by the central board of health, London, relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins. Lancet 1832; 18:274-280
3. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Ann Intensive Care 2011; 1:1
4. Hilton AK, Bellomo R. A critique of fluid bolus resuscitation in severe sepsis. Crit Care 2012; 16:302
5. Hilton AK, Bellomo R. Totem and Taboo: Fluids in sepsis. Crit Care 2011; 15:164
6. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012; 380:756-766
7. Rivers E,Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
8. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74
9. Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39:259-265
10. Liu KD, Thompson BT, Ancukiewicz M, et al. Acute kidney injury in patients with acute lung injury: Impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 2011; 39:2665-2671
11. Shum HP, Lee FM, Chan KC, Yan WW. Interaction between fluid balance and disease severity on patient outcome in the critically ill. J Crit Care 2011; 26:613-619
12. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76:422-427
13. Bellomo R, Cass A, Cole L, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med 2012; 40:1753-1760
14. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
15. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
16. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134
17. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
18. Wise R, Fourie C, Richards GA. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1266-1267
19. Magder S. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1265
20. Von Heymann C, Sander M, Spies CD. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1265-1266
21. Chappell D, Jacob M. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1266
22. Bracco D, Schricker T, Carvalho G. Insulin and pentastarch for severe sepsis. N Engl J Med 2008; 358:2072; author reply 2074-2075
23. Muller L, Jaber S, Lefrant JY. Insulin and pentastarch for severe sepsis. N Engl J Med 2008; 358:2072-2073; author reply 2074-2075
24. Lobo DN, Stanga Z, Aloysius MM, et al. Effect of volume loading with 1 l intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: A randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38:464-470
25. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001; 95:849-856
26. Bruegger D, Jacob M, Rehm M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 1999; 289: H1993
27. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256: 18-24
28. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71:726-735
29. Aksu U, Bezemer R, Yavuz B, et al. Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation 2012; 83:767-773
30. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572
31. Saotome T, Ishikawa K, May CN, et al. The impact of experimental hypoperfusion on subsequent kidney function. Intensive Care Med 2010; 36:533-540
32. Russell JA. Adding fuel to the fire-The supranormal oxygen delivery trials controversy. Crit Care Med 1998; 26:981-983
33. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
34. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
35. Lin SM, Huang CD, Lin HC, et al. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial. Shock 2006; 26:551-557
36. Rivers EP, Katranji M, Jaehne KA, et al. Early interventions in severe sepsis and septic shock: A review of the evidence one decade later. Minerva Anestesiol 2012; 78:712-724
37. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178
38. Lichtwarck-Aschoff M, Zeravik J, Pfeiffer UJ. Intrathoracic blood volume accurately reflects circulatory volume status in critically ill patients with mechanical ventilation. Intensive Care Med 1992; 18:142-147
39. Marik PE, Cavallazzi R, Vasu T, Hirani A. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature. Crit Care Med 2009; 37:2642-2647
40. Lee CH, Wang JY, Wu YK, et al. Pulse pressure power spectrum predicts volume responsiveness in shock patients without sedation. Shock 2010; 33:454-459
41. Pranskunas A, Koopmans M, Koetsier PM, et al. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med 2012 (in press).
42. McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg 2003; 96:1572-1577
43. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507
44. Vamvakas EC, Blajchman MA. Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113:3406-3417
45. Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-Term survival after cardiac surgery. Anesth Analg 2009; 108:1741-1746
46. Prowle JR, Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2010; 16:332-336
47. Palevsky PM, Metnitz PG, Piccinni P, Vinsonneau C. Selection of endpoints for clinical trials of acute renal failure in critically ill patients. Curr Opin Crit Care 2002; 8:515-518
48. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of6%hydroxyethylstarch 130/0.4 versus 0.9%NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16:R94
49. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98:216-224
50. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: An updated systematic review and meta-Analysis. Anesth Analg 2012; 114:159-169
51. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25:659.e1-659.e8
52. Dolecek M, Svoboda P, Kantorova I, et al. Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: A randomized controlled trial. Hepatogastroenterology 2009; 56:1622-1628
53. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2013; 41:580-637
54. James MF, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107:693-702
55. Van Der Linden P, James M, Mythen M, Weiskopf RB. Review article: Safety of modern starches used during surgery. Anesth Analg 2013; 116:35-48
56. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118:387-394
57. Bagchi A, Eikermann M. Mashed potatoes and maize: Are the starches safe? Anesthesiology 2013; 118:244-247
58. Westphal M, James MF, Kozek-Langenecker S, et al. Hydroxyethyl starches: Different products-different effects. Anesthesiology 2009; 111:187-202
59. Wiedersheim M. An investigation of oxyethylstarch as a new plasma volume expander in animals. Arch Int Pharmacodyn Ther 1957; 111:353-361
60. Sommermeyer R, Cech F, Schossow R. Differences in chemical structures between waxy maize-And potato-starch-based hydroxyethyl starch volume therapeutics. Transfus Altern Transfus Med 2007; 9:127-133
61. Singh N, Singh S, Kaur L, et al. Morphological, thermal and rheological properties of starches from different botanical sources. Food Chem 2003; 81:219-231
62. Blennow A, Bay-Smidt AM,Olsen CE, Moller BL. The distribution of covalently bound phosphate in the starch granule in relation to starch crystallinity. Int J Biol Macromol 2000; 27:211-218
63. Blennow A, Mette Bay-Smidt A, Bauer R. Amylopectin aggregation as a function of starch phosphate content studied by size exclusion chromatography and on-line refractive index and light scattering. Int J Biol Macromol 2001; 28:409-420
64. Tabata S, Hizukuri S. Studies on starch phosphate. Part 2. Isolation of glucose 3-phosphate and maltose phosphate by acid hydrolysis of potato starch. Starch 1971; 23:267-271
65. Takeda Y, Hizukuri S. Actions of Aspergillus oryzae alpha-Amylase, potato phosphorylase, and rabbit muscle phosphorylase a and b on phosphorylated (1!4)-Alpha-D-glucan. Carbohydr Res 1986; 153:295-307
66. Godet MC, Tran V, Colonna P, Buleon A. Inclusion/exclusion of fatty acids in amylose complexes as a function of the fatty acid chain length. Int J Biol Macromol 1995; 17:405-408
67. Szejtli J, Bá nky-Elöd I. Determination of dissociation-constants of amylose clathrates. Stä rke 1978; 30:85-91
68. Lehmann G, Marx G, Forster H. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1. Drugs R D 2007; 8:229-240
69. Langanke C, Hinkelmann J, Fischer LG, et al. Effects of balanced hydroxyethyl starch solutions on gut mucosal microcirculation and exhaled nitric oxide in septic rats. Eur J Anaesthesiol (in press
70. Zarychanski R, Abou-Setta AM, Turgeon AF. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation-A systematic review and metaanalysis. JAMA 2013; 309:678-688
71. Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-Analysis and trial sequential analysis. BMJ 2013; 346:f839
72. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med (in press